Assessing

EarthID Sets New Standard in Decentralized Identity Management

[London, Feb 13, 2024] — EarthID has been assessed by the Government Blockchain Association’s (GBA) Blockchain Maturity Model (BMM), earning a Maturity Level One rating. ‘’We are thrilled to have earned GBA's BMM rating. This achievement is more than a milestone; it's a reflection of our unwavering commitment to providing secure, user-centric identity solutions whilst meeting the demanding requirements of enterprise clients.’’ stated Priya Guliani, EarthID’s CEO. EarthID is a decentralized identity platform, enabling organizations to safeguard and minimize personally identifiable customer data, prevent identity fraud, while empowering users with

Unveiling the Inaugural Global Protocol Report: A Comprehensive Analysis of Blockchain Protocols that is Poised to Aid WEB3 Decisions

Crypto Oasis, Crypto Valley, the DLT Science Foundation and Inacta Ventures Join Forces in a Groundbreaking Initiative that Will Help Navigate the Blockchain Trilemma Highlights: The report has unprecedented transparency and clarity, granular insights, and an evolving analysis of DLT protocol attributes. It will help industry experts and novices gain foundational knowledge on DLT concepts, WEB3 ecosystem infrastructure, the evolution of the Blockchain landscape, and the role of capital, talent, infrastructure, and regulations in WEB3 innovation. The Global Protocol Report introduces a comprehensive framework for assessing the maturity of DLT

NKGen Biotech Advances Alzheimer’s Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

December 29, 2023 - NKGen Biotech, Inc. (Nasdaq: NKGN) is making strides in Alzheimer's disease (AD) treatment with the dosing of the first patient in its Phase 1/2a trial for SNK01, an autologous natural killer (NK) cell therapy. The innovative product, designed for moderate AD, has demonstrated promising results in neuroinflammation and cognitive function during its Phase 1 safety trial. Key Points: SNK01 Efficacy: NKGen's SNK01, a cryopreserved autologous NK cell therapy, showed improvement in neuroinflammation and cognitive function in the Phase 1 dose-escalation safety trial. The therapy boasts enhanced

Navigating the Regulatory Landscape: KARM Legal Releases a Report Assessing Regulatory Framework for Virtual Assets

The UAE's Pioneering Efforts in Blockchain and Crypto are Shaping the Future of Finance. March 8, 2023, Dubai, The United Arab Emirates- KARM Legal Consultants, a leading law firm specializing in Blockchain, Cryptocurrency, Web3 & Fintech in the UAE has, in collaboration with prominent legal experts – Mr. Eric Hess (Hess Legal Counsel), Mr. Jonathan Geen, Mr. Andreas Glarner (MME) and Mr. Thomas Nagele (Nagele Attorneys) and the regional Blockchain Ecosystem Crypto Oasis, published a new report analyzing the regulatory landscape for virtual assets in various jurisdictions. The report was